Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
PR Newswire —
ALAMEDA, Calif., Feb. 25, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2025. Financial Highlights: Revenue of $385.4 million for the fourth quarter of...